Verily Impact Investors
Verily is an Alphabet precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions
Investors
Founded Date:
2015-01-01
Funding Status:
Private Equity
Total Funding:
3500000000.0
Employee Number:
1001-5000
Headquarters:
South San Francisco, California, United States
Last Funding Date:
2022-09-28
Investors Number:
6
Last Funding Type:
Secondary Market
Estimated Revenue:
$100M to $500M
Acquisitions Number:
Made Acquisitions
Number Of Exists:
4
Industry:
End-to-End Drug Development